These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12370290)

  • 1. The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin.
    McMahon LP; Choi KM; Lin TA; Abraham RT; Lawrence JC
    Mol Cell Biol; 2002 Nov; 22(21):7428-38. PubMed ID: 12370290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target of rapamycin (TOR)-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1.
    Beugnet A; Wang X; Proud CG
    J Biol Chem; 2003 Oct; 278(42):40717-22. PubMed ID: 12912989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of rapamycin sensitivity in breast cancer cells.
    Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F
    Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
    Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
    J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin.
    Shu L; Zhang X; Houghton PJ
    J Biol Chem; 2002 May; 277(19):16726-32. PubMed ID: 11875068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1.
    El-Chaâr D; Gagnon A; Sorisky A
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the protein kinase activity of mTOR.
    Lawrence JC; Lin TA; McMahon LP; Choi KM
    Curr Top Microbiol Immunol; 2004; 279():199-213. PubMed ID: 14560959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies.
    Mothe-Satney I; Brunn GJ; McMahon LP; Capaldo CT; Abraham RT; Lawrence JC
    J Biol Chem; 2000 Oct; 275(43):33836-43. PubMed ID: 10942774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of mammalian target of rapamycin activity by increased cAMP in 3T3-L1 adipocytes.
    Scott PH; Lawrence JC
    J Biol Chem; 1998 Dec; 273(51):34496-501. PubMed ID: 9852118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB.
    Varma S; Khandelwal RL
    Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.
    Mita MM; Mita A; Rowinsky EK
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S169-77. PubMed ID: 14508096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus.
    Brunn GJ; Fadden P; Haystead TA; Lawrence JC
    J Biol Chem; 1997 Dec; 272(51):32547-50. PubMed ID: 9405468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
    Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor.
    Choi KM; McMahon LP; Lawrence JC
    J Biol Chem; 2003 May; 278(22):19667-73. PubMed ID: 12665511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In rat hepatocytes glucagon increases mammalian target of rapamycin phosphorylation on serine 2448 but antagonizes the phosphorylation of its downstream targets induced by insulin and amino acids.
    Mothe-Satney I; Gautier N; Hinault C; Lawrence JC; Van Obberghen E
    J Biol Chem; 2004 Oct; 279(41):42628-37. PubMed ID: 15292249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1.
    Burnett PE; Barrow RK; Cohen NA; Snyder SH; Sabatini DM
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1432-7. PubMed ID: 9465032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR.
    Wang L; Lawrence JC; Sturgill TW; Harris TE
    J Biol Chem; 2009 May; 284(22):14693-7. PubMed ID: 19346248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR.
    Dutton A; Reynolds GM; Dawson CW; Young LS; Murray PG
    J Pathol; 2005 Mar; 205(4):498-506. PubMed ID: 15714459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.